Jessica Oien
General Counsel bei BOUNDLESS BIO, INC.
Vermögen: - $ am 30.04.2024
Profil
Jessica Oien's current job is as the Secretary & Chief Legal Officer at Boundless Bio, Inc. She started this position in 2024.
Her former jobs include being the Senior Director-Legal Affairs at Verus Pharmaceuticals, Inc. from 2007 to 2008, and at Elan Pharmaceuticals LLC from 2001 to 2007.
She also worked as the Vice President-Legal Affairs & Compliance at Somaxon Pharmaceuticals, Inc., and as a Corporate Counsel at Brobeck, Phleger & Harrison LLP.
Additionally, she served as the Vice President-Compliance at Otonomy, Inc. from 2015 to 2018, and at Pernix Therapeutics Holdings, Inc. She was also the Senior Vice President & General Counsel at Cidara Therapeutics, Inc. from 2018 to 2021.
Ms. Oien's education includes an undergraduate degree from North Dakota State University and a graduate degree from Loyola Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BOUNDLESS BIO INC.
-.--% | 27.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Jessica Oien
| Unternehmen | Position | Beginn |
|---|---|---|
| BOUNDLESS BIO, INC. | General Counsel | 01.08.2021 |
Ehemalige bekannte Positionen von Jessica Oien
| Unternehmen | Position | Ende |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | General Counsel | 01.09.2021 |
| OTONOMY | Compliance Officer | 01.01.2018 |
Verus Pharmaceuticals, Inc.
 Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verus Pharmaceuticals, Inc. was provided pediatric-oriented pharmaceutical products. The company was founded by David A. Socks, James Carroll Blair, Robert W. Keith, Cam L. Garner and David F. Hale in 2002 and was headquartered in San Diego, CA. | General Counsel | 01.01.2008 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | General Counsel | 01.01.2007 |
| Brobeck, Phleger & Harrison LLP | General Counsel | - |
Ausbildung von Jessica Oien
| Loyola Law School | Graduate Degree |
| North Dakota State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Health Technology |
Verus Pharmaceuticals, Inc.
Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verus Pharmaceuticals, Inc. was provided pediatric-oriented pharmaceutical products. The company was founded by David A. Socks, James Carroll Blair, Robert W. Keith, Cam L. Garner and David F. Hale in 2002 and was headquartered in San Diego, CA. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
| Brobeck, Phleger & Harrison LLP | Commercial Services |
